Cargando…
Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil
We describe a case of prolonged COVID-19 caused by the SARS-CoV-2 Gamma variant in a fully vaccinated healthcare worker, 387 days after an infection caused by lineage B.1.1.33. Infections were confirmed by whole-genome sequencing and corroborated by the detection of neutralizing antibodies in conval...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553653/ https://www.ncbi.nlm.nih.gov/pubmed/34757006 http://dx.doi.org/10.1016/j.ijid.2021.10.048 |
_version_ | 1784591624256356352 |
---|---|
author | Penetra, Stephanie L.S. da Silva, Michele F.B. Resende, Paola Pina-Costa, Anielle Santos, Heloisa F.P. Guaraldo, Lusiele Calvet, Guilherme A. Ogrzewalska, Maria Arantes, Ighor Zukeram, Ketiuce de Araújo, Mia F. Lima, Ana Beatriz Machado Lopes, Renata Serrano Lira-Silva, Larissa R. Moraes, Isabella V. Wakimoto, Mayumi D. Fuller, Trevon L. Gabaglia, Claudia Raja Espíndola, Otávio M. Bonaldo, Myrna C. Daniel-Ribeiro, Cláudio Tadeu Whitworth, Jimmy Smith, Chris Nielsen-Saines, Karin Pauvolid-Correa, Alex Siqueira, Marilda M. Brasil, Patricia |
author_facet | Penetra, Stephanie L.S. da Silva, Michele F.B. Resende, Paola Pina-Costa, Anielle Santos, Heloisa F.P. Guaraldo, Lusiele Calvet, Guilherme A. Ogrzewalska, Maria Arantes, Ighor Zukeram, Ketiuce de Araújo, Mia F. Lima, Ana Beatriz Machado Lopes, Renata Serrano Lira-Silva, Larissa R. Moraes, Isabella V. Wakimoto, Mayumi D. Fuller, Trevon L. Gabaglia, Claudia Raja Espíndola, Otávio M. Bonaldo, Myrna C. Daniel-Ribeiro, Cláudio Tadeu Whitworth, Jimmy Smith, Chris Nielsen-Saines, Karin Pauvolid-Correa, Alex Siqueira, Marilda M. Brasil, Patricia |
author_sort | Penetra, Stephanie L.S. |
collection | PubMed |
description | We describe a case of prolonged COVID-19 caused by the SARS-CoV-2 Gamma variant in a fully vaccinated healthcare worker, 387 days after an infection caused by lineage B.1.1.33. Infections were confirmed by whole-genome sequencing and corroborated by the detection of neutralizing antibodies in convalescent serum samples. Considering the permanent exposure of this healthcare worker to SARS-CoV-2, the waning immunity after the first infection, the low efficacy of the inactivated vaccine at preventing COVID-19, the immune escape of the Gamma variant (VOC), and the burden of post-COVID syndrome, this individual would have benefited from an additional dose of a heterologous vaccine. |
format | Online Article Text |
id | pubmed-8553653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85536532021-10-29 Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil Penetra, Stephanie L.S. da Silva, Michele F.B. Resende, Paola Pina-Costa, Anielle Santos, Heloisa F.P. Guaraldo, Lusiele Calvet, Guilherme A. Ogrzewalska, Maria Arantes, Ighor Zukeram, Ketiuce de Araújo, Mia F. Lima, Ana Beatriz Machado Lopes, Renata Serrano Lira-Silva, Larissa R. Moraes, Isabella V. Wakimoto, Mayumi D. Fuller, Trevon L. Gabaglia, Claudia Raja Espíndola, Otávio M. Bonaldo, Myrna C. Daniel-Ribeiro, Cláudio Tadeu Whitworth, Jimmy Smith, Chris Nielsen-Saines, Karin Pauvolid-Correa, Alex Siqueira, Marilda M. Brasil, Patricia Int J Infect Dis Case Report We describe a case of prolonged COVID-19 caused by the SARS-CoV-2 Gamma variant in a fully vaccinated healthcare worker, 387 days after an infection caused by lineage B.1.1.33. Infections were confirmed by whole-genome sequencing and corroborated by the detection of neutralizing antibodies in convalescent serum samples. Considering the permanent exposure of this healthcare worker to SARS-CoV-2, the waning immunity after the first infection, the low efficacy of the inactivated vaccine at preventing COVID-19, the immune escape of the Gamma variant (VOC), and the burden of post-COVID syndrome, this individual would have benefited from an additional dose of a heterologous vaccine. The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022-01 2021-10-29 /pmc/articles/PMC8553653/ /pubmed/34757006 http://dx.doi.org/10.1016/j.ijid.2021.10.048 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Case Report Penetra, Stephanie L.S. da Silva, Michele F.B. Resende, Paola Pina-Costa, Anielle Santos, Heloisa F.P. Guaraldo, Lusiele Calvet, Guilherme A. Ogrzewalska, Maria Arantes, Ighor Zukeram, Ketiuce de Araújo, Mia F. Lima, Ana Beatriz Machado Lopes, Renata Serrano Lira-Silva, Larissa R. Moraes, Isabella V. Wakimoto, Mayumi D. Fuller, Trevon L. Gabaglia, Claudia Raja Espíndola, Otávio M. Bonaldo, Myrna C. Daniel-Ribeiro, Cláudio Tadeu Whitworth, Jimmy Smith, Chris Nielsen-Saines, Karin Pauvolid-Correa, Alex Siqueira, Marilda M. Brasil, Patricia Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil |
title | Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil |
title_full | Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil |
title_fullStr | Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil |
title_full_unstemmed | Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil |
title_short | Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil |
title_sort | post-acute covid-19 syndrome after reinfection and vaccine breakthrough by the sars-cov-2 gamma variant in brazil |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553653/ https://www.ncbi.nlm.nih.gov/pubmed/34757006 http://dx.doi.org/10.1016/j.ijid.2021.10.048 |
work_keys_str_mv | AT penetrastephaniels postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT dasilvamichelefb postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT resendepaola postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT pinacostaanielle postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT santosheloisafp postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT guaraldolusiele postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT calvetguilhermea postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT ogrzewalskamaria postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT arantesighor postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT zukeramketiuce postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT dearaujomiaf postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT limaanabeatrizmachado postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT lopesrenataserrano postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT lirasilvalarissar postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT moraesisabellav postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT wakimotomayumid postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT fullertrevonl postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT gabagliaclaudiaraja postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT espindolaotaviom postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT bonaldomyrnac postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT danielribeiroclaudiotadeu postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT whitworthjimmy postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT smithchris postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT nielsensaineskarin postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT pauvolidcorreaalex postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT siqueiramarildam postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil AT brasilpatricia postacutecovid19syndromeafterreinfectionandvaccinebreakthroughbythesarscov2gammavariantinbrazil |